Adverse drug reactions in patients with HIV infection

Adverse Drug Reaction Bulletin

Volumn , Issue 178, 1996, Pages 675-678

  Ellis, C J ^a   Leung, D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CLINDAMYCIN; COTRIMOXAZOLE; DIDANOSINE; FLUCONAZOLE; FOSCARNET; PENTAMIDINE; RIFAMPICIN; TUBERCULOSTATIC AGENT; ZALCITABINE; ZIDOVUDINE;

ADVERSE DRUG REACTION; BONE MARROW DISEASE; DRUG HYPERSENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGLYCEMIA; NEPHROTOXICITY; OPPORTUNISTIC INFECTION; PANCREATITIS; PERIPHERAL NERVE INJURY; PSEUDOMEMBRANOUS COLITIS; RASH; SHORT SURVEY; SKIN MANIFESTATION;

EID: 0029843214     PISSN: 00446394     EISSN: None     Source Type: Journal    
DOI: 10.1097/00012995-199606000-00001     Document Type: Short Survey

References (22)

1. Fischl MA. Treatment of HIV infection. In: Sande MA, Volberding PA, eds. The medical management of AIDS. Philadelphia and London: WB Saunders Company, 1995.
2. Gazzard B. Summary of latest data from Delta. Presented to 3rd Conference on Retrovirus and Opportunistic Infections. Washington DC, February 1996.
3. Rachlis A, Fanning MM. Zidovudine toxicity. Clinical features and management. Drug Safety 1993; 8: 312-20.
4. Zidovudine for the prevention of HIV transmission from mother to infant. Morbidity and Mortality Weekly Reports 1994; 43: 285-7.
5. Zidovudine for mother, fetus and child: hope or poison? Lancet 1994; 334: 207-9.
6. Moyle GJ, Nelson MR, Hawkins D, Gazzard BG. The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine. Quarterly Journal of Medicine 1993; 86: 155-63.
7. Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Valentine F. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. Journal of Acquired Immune Deficiency Syndromes 1992; 5: 60-4.
8. King E, ed. A-Z of treatments - 3TC. HIV and AIDS Treatments. London: National AIDS Manual Publications, 1995: 112-14.
9. Pertel P, Hirschtick R. Adverse reactions to dapsone in persons infected with human immunodeficiency virus. Clinical Infectious Diseases. 1994; 18: 630-2.
10. Ellis CJ. Dapsone and methaemoglobinaemia. In: Aronson JK, van Boxtel CJ, eds. Side Effects of Drugs Annual 17 1993: 352-3.
11. Langtry, HD. Focus on ganciclovir. Drugs 1994; 48: 445-84.
12. Benson CA. Treatment of disseminated disease due to Mycobacterium avium complex in patients with AIDS. Clinical Infectious Diseases 1994; 18 Supplement 3: 237-42.
13. Peloquin CA. Controversies in the management of Mycobacterium avium complex infections in AIDS patients. Annals of Pharmacotherapy 1993; 27: 928-37.
14. Johnson S, Johnson FN. Rifabutin. Contemporary Pharmacotherapy 1995; 3: 93-151.
15. Lee BL, Wong D, Benowitz NL, Sullam PM. Altered patterns of drug metabolism in patients with AIDS. Clinical Pharmacology and Therapeutics 1993; 53: 529-34.
16. Lazar JK, Wilmer KD. Drug interaction with fluconazole. Reviews of Infectious Disease. 1990; 12 supplement 3: 327-33.
17. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. New England Journal of Medicine. 1993; 328: 1670-4.
18. Gluckstein D, Ruskin J. Rapid early desensitisation to trimethoprim-sulphamethaxozole. Clinical Infectious Diseases. 195; 20: 849-53.
19. Caumes E, Bocquet H, Guermonprez G, Rogeaux O. Adverse cutaneous reactions to pyrimethanune-sulphadiazine and pyrimethamine-clindamycin in patients with AIDS and toxoplasmic encephalitis. Clinical Infectious Diseases. 1995; 21: 656-8.
20. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced HIV infection. New England Journal of Medicine. 1991; 324: 289-94.
21. Jones BE, Otaya M, Antoniskis D, Sian S, Wang F. A prospective evaluation of antituberculous therapy in patients with HIV infection. Americal Journal of Respiratory Critical Care Medicine 1994; 150: 1499-1502.
22. Nunn P, Kibuga D, Gathia S. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet 1991; 337: 627-30.